PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 7659444-3 1995 In mice, the NK1 antagonist, CP 99,994, preferentially (inhibitory dose50 (ID50) = 4.4) inhibited the late phase (LP) as compared to the early phase (EP) (16.1) of formalin-induced licking (FIL). 3-(2-methoxybenzylamino)-2-phenylpiperidine 29-38 tachykinin 1 Mus musculus 13-16 10454146-4 1999 In addition, the intraplantar application of CP-99994 (1 pmol), a substance P (NK1) receptor antagonist, but not CP-100263 (1 pmol), an inactive derivative, also markedly reduced the LPA responses. 3-(2-methoxybenzylamino)-2-phenylpiperidine 45-53 tachykinin 1 Mus musculus 66-77 9190858-7 1997 The more potent inhibitor of [3H] SP binding, (+)-(2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine (CP-99,994), was approximately 10 times more potent in inhibiting NMDA-induced activity than CP-96,345. 3-(2-methoxybenzylamino)-2-phenylpiperidine 46-101 tachykinin 1 Mus musculus 34-36